Full-Service Genomics Solis Agrosciences delivers end-to-end genomics sequencing, genotyping and data services for gene-edited and transgenic crops, enabling customers to move quickly from discovery to field-ready traits. The recent acquisition of a genomics platform strengthens capabilities and positions Solis as a one-stop R&D partner for crop improvement.

Strategic Partnerships The company already collaborates with GenXtraits for R&D services and has licensing arrangements with Pairwise's Fulcrum Platform, signaling openness to external collaborations and access to CRISPR-based trait development.

Leadership Growth New Chief Business Officer appointed in 2025 and a Series A financing of 4.5 million in 2024 demonstrate an active growth trajectory and increased focus on business development and capacity expansion.

Midwest Footprint Operating from St. Louis in the 39 North Ag Biotech district, Solis targets regional agri-business and university partnerships, offering a locally accessible, specialized R&D hub in the Midwest.

IP and Tech Edge Investments in genomics capabilities and licensing transactions indicate a defensible, technology-forward position that can be leveraged to win mid-market customers seeking advanced breeding, genotyping and data analytics.